Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
Front Cell Infect Microbiol ; 14: 1297321, 2024.
Article in English | MEDLINE | ID: mdl-38481660

ABSTRACT

Chagas' is a neglected disease caused by the eukaryotic kinetoplastid parasite, Trypanosoma cruzi. Currently, approximately 8 million people are infected worldwide, most of whom are in the chronic phase of the disease, which involves cardiac, digestive, or neurologic manifestations. There is an urgent need for a vaccine because treatments are only effective in the initial phase of infection, which is generally underdiagnosed. The selection and combination of antigens, adjuvants, and delivery platforms for vaccine formulations should be designed to trigger mixed humoral and cellular immune responses, considering that T. cruzi has a complex life cycle with both intracellular and bloodstream circulating parasite stages in vertebrate hosts. Here, we report the effectiveness of vaccination with a T. cruzi-specific protein family (TcTASV), employing both recombinant proteins with aluminum hydroxide and a recombinant baculovirus displaying a TcTASV antigen at the capsid. Vaccination stimulated immunological responses by producing lytic antibodies and antigen-specific CD4+ and CD8+ IFNÉ£ secreting lymphocytes. More than 90% of vaccinated animals survived after lethal challenges with T. cruzi, whereas all control mice died before 30 days post-infection. Vaccination also induced a strong decrease in chronic tissue parasitism and generated immunological memory that allowed vaccinated and infected animals to control both the reactivation of the infection after immunosuppression and a second challenge with T. cruzi. Interestingly, inoculation with wild-type baculovirus partially protected the mice against T. cruzi. In brief, we demonstrated for the first time that the combination of the baculovirus platform and the TcTASV family provides effective protection against Trypanosoma cruzi, which is a promising vaccine for Chagas disease.


Subject(s)
Chagas Disease , Parasites , Protozoan Vaccines , Trypanosoma cruzi , Vaccines , Humans , Animals , Mice , Baculoviridae/genetics , Antigens, Protozoan/genetics , Chagas Disease/parasitology , Trypanosoma cruzi/genetics , Vaccination , Protozoan Vaccines/genetics
2.
Microb Pathog ; 183: 106327, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37640275

ABSTRACT

Chagas heart disease (CHD), caused by the protozoan parasite Trypanosoma cruzi, consists of a progressive myocarditis which may lead to congestive heart failure or sudden death. Previous work from our laboratory has demonstrated that the experimental infection of mice with T. cruzi positively modulates the expression of CD40 by myocardial cells, whose ligation potentiates IFN-γ-induced IL-6 production. Herein, we investigate the role of the CD40/CD40L interaction during T. cruzi infection using a CD40-targeted peptide and evaluating parasitological, histopathological and serological parameters. To reproduce acute and chronic phases of theT. cruzi infection, we used two experimental models: Balb/c mice infected with RA strain of T. cruzi (Balb/c-RA) and C3H/HeN mice infected with Sylvio X-10/4 parasites (C3H/HeN-Sylvio), respectively. Balb/c-RA treated with CD40-tageted peptide since day 0 post infection (pi), were unable to control the acute infection dying within 23-26 days pi with marked tissue damage. In contrast, treatment of C3H/HeN-Sylvio treated with CD40-targeted peptide starting on day 30 pi resulted in amelioration of myocardial and skeletal muscle damage. Altogether, our results indicate a dual role of CD40/CD40L dyad in the control of T.cruzi infection as well as the associated pathology, depending on the timing of treatment initiation.


Subject(s)
Chagas Disease , Trypanosoma cruzi , Animals , Mice , Mice, Inbred C3H , CD40 Ligand , CD40 Antigens , Mice, Inbred BALB C
4.
Exp Parasitol ; 220: 108044, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33253715

ABSTRACT

Trypanosoma cruzi is the causative agent of Chagas disease, which is endemic in Latin America and around the world through mother to child transmission. The heart is the organ most frequently affected in the chronic stage of the human infection and depends on mitochondria for the required energy for its activity. Cyclophilins are involved in protein folding and the mitochondrial isoform, Cyclophilin D (CyPD), has a crucial role in the opening of the mitochondrial permeability transition pore. In the present study, we infected CyPD deficient mice, with ablation of the Ppif gene, with T. cruzi parasites and the course of the infection was analyzed. Parasite load, quantified by PCR, was significantly lower in skeletal and cardiac tissues of Ppif-/- mice compared to wild type mice. In vitro cultured cardiomyocytes and macrophages from mice lacking CyPD exhibited lower percentage of infected cells and number of intracellular parasites than those observed for wild type mice. Although histopathological analysis of heart and mRNA of heart cytokines showed differences between T. cruzi-infected mice compared to the uninfected animals, no significant differences were found mice due to the ablation of the Ppif gene. Our results suggest that cells deficient for mitochondrial CyPD, inhibited for the mitochondrial membrane potential collapse, reduces the severity of parasite aggression and spread of cellular infection.


Subject(s)
Chagas Disease/parasitology , Peptidyl-Prolyl Isomerase F/deficiency , Trypanosoma cruzi/physiology , Animals , Cytokines/analysis , Cytokines/genetics , DNA, Protozoan/isolation & purification , Heart/parasitology , Liver/pathology , Macrophages, Peritoneal/cytology , Macrophages, Peritoneal/parasitology , Mice , Mice, Inbred C57BL , Muscle, Skeletal/parasitology , Muscle, Skeletal/pathology , Myocardium/pathology , Myocytes, Cardiac/cytology , Myocytes, Cardiac/parasitology , Parasite Load , RNA, Messenger/analysis , RNA, Protozoan/analysis , RNA, Protozoan/isolation & purification , Spleen/pathology , Trypanosoma cruzi/genetics
5.
Article in English | MEDLINE | ID: mdl-32714876

ABSTRACT

Galectins are animal lectins with high affinity for ß-galactosides that drive the immune response through several mechanisms. In particular, the role of galectin-8 (Gal-8) in inflammation remains controversial. To analyze its role in a chronic inflammatory environment, we studied a murine model of Trypanosoma cruzi infection. The parasite induces alterations that lead to the development of chronic cardiomyopathy and/or megaviscera in 30% of infected patients. The strong cardiac inflammation along with fibrosis leads to cardiomyopathy, the most relevant consequence of Chagas disease. By analyzing infected wild-type (iWT) and Gal-8-deficient (iGal-8KO) C57BL/6J mice at the chronic phase (4-5 months post-infection), we observed that the lack of Gal-8 favored a generalized increase in heart, skeletal muscle, and liver inflammation associated with extensive fibrosis, unrelated to tissue parasite loads. Remarkably, increased frequencies of neutrophils and macrophages were observed within cardiac iGal-8KO tissue by flow cytometry. It has been proposed that Gal-8, as well as other galectins, induces the surface expression of the inner molecule phosphatidylserine on activated neutrophils, which serves as an "eat-me" signal for macrophages, favoring viable neutrophil removal and tissue injury protection, a process known as preaparesis. We found that the increased neutrophil rates could be associated with the absence of Gal-8-dependent preaparesis, leading to a diminished neutrophil-clearing capability in macrophages. Thus, our results support that Gal-8 exerts an anti-inflammatory role in chronic T. cruzi infection.


Subject(s)
Chagas Disease , Galectins/immunology , Trypanosoma cruzi , Animals , Anti-Inflammatory Agents , Disease Models, Animal , Mice , Mice, Inbred C57BL , Mice, Knockout
6.
Article in English | MEDLINE | ID: mdl-32296649

ABSTRACT

Multiple perturbations of the immune response affecting a range of cells have been reported in Trypanosoma cruzi-infected individuals and associated to clinical manifestations of chronic Chagas disease. There is a paucity of knowledge about the role of T follicular helper (Tfh) cells in this infection. Here, we sought to characterize circulating Tfh (cTfh) cells in chronic Chagas disease patients and to identify potential associations with disease severity in humans. cTfh cells were characterized by flow cytometry in freshly isolated PBMCs from 7 T. cruzi-infected asymptomatic patients (ASYMP), 5 patients with chronic chagasic dilated cardiomyopathy (CCC) and 8 healthy controls, using antibodies against chemokine receptors CXCR5, CXCR3, CCR6, and CCR7. Our results showed significant expansion of CD4+CD45RO+CXCR5+CCR6+ cells in ASYMP and CCC patients, along with a contraction of CD4+CD45RO+CXCR5+CXCR3-CCR6- (cTfh2) cells. ASYMP patients further exhibited decreased CD4+CD45RO+CXCR5+CXCR3+CCR6- (cTfh1) cells and expanded CD4+CD45RO+CXCR5+CXCR3-CCR6+ (cTfh17) cells while CCC patients exhibited significantly increased frequencies of CD4+CD45RO+CXCR5+CCR7+ cells. Linear regression analysis revealed a positive trend of CD4+CD45RO+CXCR5+CXCR3+CCR6+ (cTfh1/17) cells and negative trends of cTfh1 and cTfh2 cells as disease was more severe. There was no correlation between the frequencies of cTfh cells and circulating CD19+IgD-IgG+ cells or serum levels of T. cruzi-specific IgG. These results demonstrate that the cTfh compartment of humans chronically infected with T. cruzi comprises expanded CCR6-expressing cells and reduced cTfh2 cells. The association of discrete phenotypic changes in cTfh subsets with different clinical forms suggests the potential contribution of T follicular helper cells to Chagas heart disease progression.


Subject(s)
Chagas Disease , T Follicular Helper Cells , CD4-Positive T-Lymphocytes , Humans , Receptors, CXCR5 , T-Lymphocytes, Helper-Inducer
7.
JCI Insight ; 4(18)2019 09 19.
Article in English | MEDLINE | ID: mdl-31479429

ABSTRACT

Chagas disease is a lifelong pathology resulting from Trypanosoma cruzi infection. It represents one of the most frequent causes of heart failure and sudden death in Latin America. Herein, we provide evidence that aerobic glycolytic pathway activation in monocytes drives nitric oxide (NO) production, triggering tyrosine nitration (TN) on CD8+ T cells and dysfunction in patients with chronic Chagas disease. Monocytes from patients exhibited a higher frequency of hypoxia-inducible factor 1α and increased expression of its target genes/proteins. Nonclassical monocytes are expanded in patients' peripheral blood and represent an important source of NO. Monocytes entail CD8+ T cell surface nitration because both the frequency of nonclassical monocytes and that of NO-producing monocytes positively correlated with the percentage of TN+ lymphocytes. Inhibition of glycolysis in in vitro-infected peripheral blood mononuclear cells decreased the inflammatory properties of monocytes/macrophages, diminishing the frequency of IL-1ß- and NO-producing cells. In agreement, glycolysis inhibition reduced the percentage of TN+CD8+ T cells, improving their functionality. Altogether, these results clearly show that glycolysis governs oxidative stress on monocytes and modulates monocyte-T cell interplay in human chronic Chagas disease. Understanding the pathological immune mechanisms that sustain an inflammatory environment in human pathology is key to designing improved therapies.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Cell Communication/immunology , Chagas Disease/immunology , Glycolysis/immunology , Monocytes/metabolism , Trypanosoma cruzi/immunology , Adult , Animals , CD8-Positive T-Lymphocytes/drug effects , Case-Control Studies , Cell Communication/drug effects , Chagas Disease/blood , Chagas Disease/drug therapy , Chlorocebus aethiops , Coculture Techniques , Female , Glycolysis/drug effects , Humans , Lymphocyte Activation/drug effects , Male , Middle Aged , Monocytes/drug effects , Monocytes/immunology , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Oxidative Stress/immunology , Primary Cell Culture , Protozoan Proteins/immunology , Tyrosine/metabolism , Vero Cells , Young Adult
8.
PLoS One ; 13(9): e0203462, 2018.
Article in English | MEDLINE | ID: mdl-30183775

ABSTRACT

Trypanosoma cruzi is a genetically heterogeneous group of organisms that cause Chagas disease. It has been long suspected that the clinical outcome of the disease and response to therapeutic agents are, at least in part, related to the genetic characteristics of the parasite. Herein, we sought to validate the significance of the genotype of T. cruzi isolates recovered from patients with different clinical forms of Chagas disease living in Argentina on their biological behaviour and susceptibility to drugs. Genotype identification of the newly established isolates confirmed the reported predominance of TcV, with a minor frequency of TcI. Epimastigote sensitivity assays demonstrated marked dissimilar responses to benznidazole, nifurtimox, pentamidine and dihydroartemisinin in vitro. Two TcV isolates exhibiting divergent response to benznidazole in epimastigote assays were further tested for the expression of anti-oxidant proteins. Benznidazole-resistant BOL-FC10A epimastigotes had decreased expression of Old Yellow Enzyme and cytosolic superoxide dismutase, and overexpression of mitochondrial superoxide dismutase and tryparedoxin- 1, compared to benznidazole-susceptible AR-SE23C parasites. Drug sensitivity assays on intracellular amastigotes and trypomastigotes reproduced the higher susceptibility of AR-SE23C over BOL-FC10A parasites to benznidazole observed in epimastigotes assays. However, the susceptibility/resistance profile of amastigotes and trypomastigotes to nifurtimox, pentamidine and dihydroartemisinin varied markedly with respect to that of epimastigotes. C3H/He mice infected with AR-SE23C trypomastigotes had higher levels of parasitemia and mortality rate during the acute phase of infection compared to mice infected with BOL-FC10A trypomastigotes. Treatment of infected mice with benznidazole or nifurtimox was efficient to reduce patent parasitemia induced by either isolate. Nevertheless, qPCR performed at 70 dpi revealed parasite DNA in the blood of mice infected with AR-SE23C but not in BOL-FC10A infected mice. These results demonstrate high level of intra-type diversity which may represent an important obstacle for the testing of chemotherapeutic agents.


Subject(s)
Chagas Disease/metabolism , Drug Resistance/drug effects , Genotype , Phenotype , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/metabolism , Adult , Animals , Argentina , Chagas Disease/drug therapy , Chagas Disease/genetics , Chlorocebus aethiops , Female , Humans , Male , Mice , Middle Aged , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Trypanosoma cruzi/genetics , Vero Cells
9.
Article in English | MEDLINE | ID: mdl-29046868

ABSTRACT

Disclosing virulence factors from pathogens is required to better understand the pathogenic mechanisms involved in their interaction with the host. In the case of Trypanosoma cruzi several molecules are associated with virulence. Among them, the trans-sialidase (TS) has arisen as one of particular relevance due to its effect on the immune system and involvement in the interaction/invasion of the host cells. The presence of conserved genes encoding for an inactive TS (iTS) isoform is puzzlingly restricted to the genome of parasites from the Discrete Typing Units TcII, TcV, and TcVI, which include highly virulent strains. Previous in vitro results using recombinant iTS support that this isoform could play a different or complementary pathogenic role to that of the enzymatically active protein. However, direct evidence involving iTS in in vivo pathogenesis and invasion is still lacking. Here we faced this challenge by transfecting iTS-null parasites with a recombinant gene that allowed us to follow its expression and association with pathological events. We found that iTS expression improves parasite invasion of host cells and increases their in vivo virulence for mice as shown by histopathologic findings in heart and skeletal muscle.


Subject(s)
Chagas Disease/parasitology , Glycoproteins/metabolism , Neuraminidase/metabolism , Trypanosoma cruzi/genetics , Virulence Factors/genetics , Animals , Chagas Disease/pathology , Chlorocebus aethiops , Glycoproteins/genetics , Humans , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Models, Animal , Neuraminidase/genetics , Primary Cell Culture , Rats , Rats, Sprague-Dawley , Transfection , Trypanosoma cruzi/pathogenicity , Vero Cells , Virulence/genetics , Virulence Factors/metabolism
10.
Parasitol Res ; 115(2): 779-85, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26526953

ABSTRACT

The inflammatory response in the myocardium is an important aspect of the pathogenesis of Chagas' heart disease raised by Trypanosoma cruzi. CD40, a transmembrane type I receptor belonging to the tumor necrosis factor receptor (TNFR) family, is expressed in a broad spectrum of cell types and is crucial in several inflammatory and autoimmune diseases. Activation of CD40 through ligation to CD40L (CD154) induces multiple effects, including the secretion of proinflammatory molecules. In the present study, we examined the ability of T. cruzi to trigger the expression of CD40 in cardiac myocytes in vitro and in a murine model of chagasic cardiomyopathy. Our results indicate, for the first time, that T. cruzi is able to induce the expression of CD40 in HL-1 murine cardiomyocytes. Moreover, ligation of CD40 receptor upregulated interleukin-6 (IL-6), associated with inflammation. Furthermore, the induction of this costimulatory molecule was demonstrated in vivo in myocardium of mice infected with T. cruzi. This suggests that CD40-bearing cardiac muscle cells could interact with CD40L-expressing lymphocytes infiltrating the heart, thus contributing to inflammatory injury in chagasic cardiomyopathy.


Subject(s)
CD40 Antigens/metabolism , Chagas Cardiomyopathy/parasitology , Interleukin-6/metabolism , Myocytes, Cardiac/immunology , Trypanosoma cruzi/physiology , Animals , CD40 Antigens/genetics , Cells, Cultured , Chagas Cardiomyopathy/pathology , Disease Models, Animal , Female , Gene Expression Regulation , Interferon-gamma/pharmacology , Mice , Mice, Inbred C3H , Myocardium/pathology , Myocytes, Cardiac/parasitology , RNA, Messenger/metabolism , Real-Time Polymerase Chain Reaction , Trypanosoma cruzi/immunology
11.
PLoS Negl Trop Dis ; 9(10): e0004148, 2015.
Article in English | MEDLINE | ID: mdl-26451839

ABSTRACT

BACKGROUND: Chronic Chagas cardiomyopathy caused by Trypanosoma cruzi is the result of a pathologic process starting during the acute phase of parasite infection. Among different factors, the specific recognition of glycan structures by glycan-binding proteins from the parasite or from the mammalian host cells may play a critical role in the evolution of the infection. METHODOLOGY AND PRINCIPAL FINDINGS: Here we investigated the contribution of galectin-1 (Gal-1), an endogenous glycan-binding protein abundantly expressed in human and mouse heart, to the pathophysiology of T. cruzi infection, particularly in the context of cardiac pathology. We found that exposure of HL-1 cardiac cells to Gal-1 reduced the percentage of infection by two different T. cruzi strains, Tulahuén (TcVI) and Brazil (TcI). In addition, Gal-1 prevented exposure of phosphatidylserine and early events in the apoptotic program by parasite infection on HL-1 cells. These effects were not mediated by direct interaction with the parasite surface, suggesting that Gal-1 may act through binding to host cells. Moreover, we also observed that T. cruzi infection altered the glycophenotype of cardiac cells, reducing binding of exogenous Gal-1 to the cell surface. Consistent with these data, Gal-1 deficient (Lgals1-/-) mice showed increased parasitemia, reduced signs of inflammation in heart and skeletal muscle tissues, and lower survival rates as compared to wild-type (WT) mice in response to intraperitoneal infection with T. cruzi Tulahuén strain. CONCLUSION/SIGNIFICANCE: Our results indicate that Gal-1 modulates T. cruzi infection of cardiac cells, highlighting the relevance of galectins and their ligands as regulators of host-parasite interactions.


Subject(s)
Chagas Disease/immunology , Chagas Disease/pathology , Galectin 1/metabolism , Host-Parasite Interactions , Myocytes, Cardiac/physiology , Myocytes, Cardiac/parasitology , Trypanosoma cruzi/immunology , Adult , Aged , Animals , Brazil , Cells, Cultured , Chagas Disease/parasitology , Disease Models, Animal , Female , Humans , Male , Mice , Mice, Knockout , Middle Aged , Parasitemia , Survival Analysis
12.
Exp Parasitol ; 156: 26-31, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26024969

ABSTRACT

Therapy against Trypanosma cruzi relies on only two chemically related nitro-derivative drugs, benznidazole and nifurtimox, both limited by poor efficacy and toxicity. It is suspected that with prolonged usage of these drugs, resistant parasites will be selected, which results in risk for treatment failure over the time. Herein, we studied the in vitro activity of artesunate, the most effective drug to treat severe P. falciparum and chloroquine-resistant P. vivax, on three strains of T. cruzi originated in different regions of Latin America (Argentina, Nicaragua and Brazil). The results of these assays showed that artesunate inhibits multiplication of epimastigotes (IC50 = 50, 6.10 and 23 µM, respectively) and intracellular amastigotes (IC50 = 15, 0.12 and 6.90 µM, respectively), indicating that it represents a potent anti-T. cruzi compound in terms of inhibiting parasite multiplication in vitro. We then tested the effect of artesunate in Balb/c mice infected with Brazil strain and found that it failed to cure the infection, suggesting that the drug may be unsuitable for in vivo treatment. When infected mice were treated with high doses AS + BZ, the outcome of infection was similar to that observed in mice treated with BZ alone. Nevertheless, understanding of structure-activity relationship of artesunate might lead to the development of new and effective drugs against T. cruzi.


Subject(s)
Artemisinins/pharmacology , Chagas Disease/drug therapy , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Animals , Artemisinins/therapeutic use , Artesunate , Chlorocebus aethiops , Female , Inhibitory Concentration 50 , Male , Mice , Mice, Inbred BALB C , Structure-Activity Relationship , Trypanocidal Agents/therapeutic use , Vero Cells
13.
Parasitology ; 142(8): 1024-32, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25823521

ABSTRACT

Cyclosporin A (CsA) specifically inhibits the mitochondrial permeability transition pore (mPTP). Opening of the mPTP, which is triggered by high levels of matrix [Ca2+] and/or oxidative stress, leads to mitochondrial dysfunction and thus to cell death by either apoptosis or necrosis. In the present study, we analysed the response of Trypanosoma cruzi epimastigote parasites to oxidative stress with 5 mm H2O2, by studying several features related to programmed cell death and the effects of pre-incubation with 1 µ m of CsA. We evaluated TcPARP cleavage, DNA integrity, cytochrome c translocation, Annexin V/propidium iodide staining, reactive oxygen species production. CsA prevented parasite oxidative stress damage as it significantly inhibited DNA degradation, cytochrome c translocation to cytosol and TcPARP cleavage. The calcein-AM/CoCl2 assay, used as a selective indicator of mPTP opening in mammals, was also performed in T. cruzi parasites. H2O2 treatment decreased calcein fluorescence, but this decline was partially inhibited by pre-incubation with CsA. Our results encourage further studies to investigate if there is a mPTP-like pore and a mitochondrial cyclophilin involved in this protozoan parasite.


Subject(s)
Calcineurin Inhibitors/pharmacology , Cyclosporine/pharmacology , Mitochondrial Membrane Transport Proteins/antagonists & inhibitors , Protozoan Proteins/antagonists & inhibitors , Trypanosoma cruzi/drug effects , Apoptosis/drug effects , Cell Death/drug effects , Cyclophilins/antagonists & inhibitors , Cytochromes c/metabolism , Fluoresceins , Fluorescent Dyes , Hydrogen Peroxide/adverse effects , Mitochondrial Permeability Transition Pore , Necrosis/chemically induced , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Trypanosoma cruzi/physiology
14.
PLoS One ; 9(8): e104951, 2014.
Article in English | MEDLINE | ID: mdl-25111833

ABSTRACT

Numerous abnormalities of the peripheral blood T cell compartment have been reported in human chronic Trypanosoma cruzi infection and related to prolonged antigenic stimulation by persisting parasites. Herein, we measured circulating lymphocytes of various phenotypes based on the differential expression of CD19, CD4, CD27, CD10, IgD, IgM, IgG and CD138 in a total of 48 T. cruzi-infected individuals and 24 healthy controls. Infected individuals had decreased frequencies of CD19+CD27+ cells, which positively correlated with the frequencies of CD4+CD27+ cells. The contraction of CD19+CD27+ cells was comprised of IgG+IgD-, IgM+IgD- and isotype switched IgM-IgD- memory B cells, CD19+CD10+CD27+ B cell precursors and terminally differentiated CD19+CD27+CD138+ plasma cells. Conversely, infected individuals had increased proportions of CD19+IgG+CD27-IgD- memory and CD19+IgM+CD27-IgD+ transitional/naïve B cells. These observations prompted us to assess soluble CD27, a molecule generated by the cleavage of membrane-bound CD27 and used to monitor systemic immune activation. Elevated levels of serum soluble CD27 were observed in infected individuals with Chagas cardiomyopathy, indicating its potentiality as an immunological marker for disease progression in endemic areas. In conclusion, our results demonstrate that chronic T. cruzi infection alters the distribution of various peripheral blood B cell subsets, probably related to the CD4+ T cell deregulation process provoked by the parasite in humans.


Subject(s)
Antibodies, Protozoan/blood , Antigens, CD/blood , B-Lymphocyte Subsets/immunology , Chagas Disease/immunology , Immunologic Memory/immunology , Antigens, CD/biosynthesis , B-Lymphocyte Subsets/cytology , CD4-Positive T-Lymphocytes/immunology , Chagas Disease/parasitology , Chronic Disease , Humans , Immunoglobulin D/blood , Immunoglobulin G/blood , Immunoglobulin M/blood , Immunophenotyping , Plasma Cells/immunology , Precursor Cells, B-Lymphoid/immunology , Trypanosoma cruzi/immunology
15.
Int J Cardiol ; 168(3): 2567-74, 2013 Oct 03.
Article in English | MEDLINE | ID: mdl-23597573

ABSTRACT

BACKGROUND: The hallmark of Trypanosoma cruzi infection is cardiomyopathy that leads to end-stage heart failure. We investigated whether G-CSF, known to induce heart tissue repair by bone marrow stem cell mobilization, ameliorates T. cruzi-induced myocarditis. METHODS AND RESULTS: T. cruzi-infected C3H/He mice were treated with G-CSF and monitored for parasite burden, BMSC mobilization, cytokine profile and cardiac remodeling. G-CSF increased the expression of CXCR4, CD34, and c-Kit, indicating mobilization and migration of BMSC, some of which differentiated to cardiomyocytes as evidenced by increased levels of GATA4(+)/MEF2C(+) cells and desmin expression in chagasic hearts. G-CSF enhanced a mixed cytokine response (IL-10+TGF-ß>IFN-γ+TNF-α>IL-4) associated with increased heart inflammation and no beneficial effect on parasite control. Further, G-CSF controlled T. cruzi-induced extracellular-matrix alterations of collagens (Col I and Col llI), hydroxyproline, and glycosaminoglycan contents and promoted compensatory cardiac remodeling; however, these responses were not sufficient to control T. cruzi-induced cardiomyocyte atrophy. Benznidazole treatment prior to G-CSF resulted in the control of parasitism and parasite-induced inflammation, and subsequently, G-CSF was effective in executing the tissue repair, as evidenced by extracellular-matrix homeostasis and normalization of cardiomyocyte size in chagasic hearts. CONCLUSIONS: G-CSF treatment after T. cruzi infection enhanced migration and homing of BMSC, some of which differentiated to cardiomyocytes. Yet, G-CSF promoted a mixed (Treg>Th1>Th2) immune response that contributed to persistent inflammation and limited improvement in cardiac homeostasis. Combinatorial therapy (BZ → G-CSF) was beneficial in arresting inflammatory processes and tissue damage in chagasic hearts.


Subject(s)
Chagas Cardiomyopathy/drug therapy , Granulocyte Colony-Stimulating Factor/therapeutic use , Animals , Cell Differentiation , Chagas Cardiomyopathy/immunology , Female , Hematopoietic Stem Cell Mobilization , Male , Mice , Mice, Inbred C3H , Myocytes, Cardiac/cytology , Remission Induction
16.
PLoS One ; 8(2): e57181, 2013.
Article in English | MEDLINE | ID: mdl-23451183

ABSTRACT

Clinical symptoms of chronic Chagas disease occur in around 30% of the individuals infected with Trypanosoma cruzi and are characterized by heart inflammation and dysfunction. The pathogenesis of chronic chagasic cardiomyopathy (CCC) is not completely understood yet, partially because disease evolution depends on complex host-parasite interactions. Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine that promotes numerous pathophysiological processes. In the current study, we investigated the link between MIF and CCC progression.Immunohistochemical analysis demonstrated MIF overexpression in the hearts from chronically T. cruzi-infected mice, particularly those showing intense inflammatory infiltration. We also found that MIF exogenously added to parasite-infected murine macrophage cultures is capable of enhancing the production of TNF-α and reactive oxygen species, both with pathogenic roles in CCC. Thus, the integrated action of MIF and other cytokines and chemokines may account for leukocyte influx to the infected myocardium, accompanied by enhanced local production of multiple inflammatory mediators. We further examined by ELISA the level of MIF in the sera from chronic indeterminate and cardiomyopathic chagasic patients, and healthy subjects. CCC patients displayed significantly higher MIF concentrations than those recorded in asymptomatic T. cruzi-infected and uninfected individuals. Interestingly, increased MIF levels were associated with severe progressive Chagas heart disease, in correlation with elevated serum concentration of high sensitivity C-reactive protein and also with several echocardiographic indicators of left ventricular dysfunction, one of the hallmarks of CCC. Our present findings represent the first evidence that enhanced MIF production is associated with progressive cardiac impairment in chronic human infection with T. cruzi, strengthening the relationship between inflammatory response and parasite-driven pathology. These observations contribute to unravel the elements involved in the pathogenesis of CCC and may also be helpful for the design of novel therapies aimed to control long-term morbidity in chagasic patients.


Subject(s)
Cardiomyopathies/blood , Chagas Disease/blood , Macrophage Migration-Inhibitory Factors/blood , Animals , Cardiomyopathies/complications , Cardiomyopathies/pathology , Cell Line , Chagas Disease/complications , Chronic Disease , Disease Progression , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Humans , Immunohistochemistry , Macrophages/metabolism , Mice , Mice, Inbred C3H , Middle Aged , Reactive Oxygen Species/metabolism , Tumor Necrosis Factor-alpha/metabolism
17.
Int Immunopharmacol ; 11(8): 1024-31, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21371583

ABSTRACT

Heart failure and sudden death are the most common causes of death in patients with Chagas' disease. The main drug available for Chagas treatment is benznidazole, which eradicates Trypanosoma cruzi parasites during the acute stage of infection. However, its effectiveness during the chronic phase remains unclear. Ganglioside GM1 administration in chronically infected patients resulted to be an effective treatment for the cardiac manifestations of Chagas' disease. However, the precise mechanisms of GM1-induced improvement during chronic T. cruzi infection still remain unknown. The aim of the present study was to evaluate the potential benefits of ganglioside GM1 treatment during the chronic stage of murine chagasic infection, analyzing its influence on myocardial pathology as well as its immunomodulatory effects. The results obtained showed that GM1 therapy diminished the extent of myocardial fibrosis induced by T. cruzi in chronically infected mice. In addition, GM1 treatment resulted in a significant reduction in the myocardial expression of the fibrogenic cytokine TGF-ß as well as the proinflammatory cytokines and chemokines IFN-γ, TNF-α and CCL5/RANTES. Our experimental data indicate that GM1 could be a promising immunomodulatory agent with capacity to limit the inflammatory process leading to myocardial tissue damage in chronic chagasic patients.


Subject(s)
Chagas Cardiomyopathy/drug therapy , G(M1) Ganglioside/pharmacology , Immunologic Factors/pharmacology , Trypanosoma cruzi/drug effects , Animals , Chagas Cardiomyopathy/genetics , Chagas Cardiomyopathy/immunology , Chagas Cardiomyopathy/pathology , Chemokine CCL5/antagonists & inhibitors , Chemokine CCL5/genetics , Female , Fibrosis/drug therapy , Fibrosis/genetics , Fibrosis/pathology , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/genetics , Mice , Mice, Inbred BALB C , Myocardium/metabolism , Myocardium/pathology , Transforming Growth Factor beta/antagonists & inhibitors , Transforming Growth Factor beta/genetics , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/genetics
18.
Exp Parasitol ; 126(2): 239-44, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20493848

ABSTRACT

We describe some biological and molecular characteristics of a Trypanosoma cruzi isolate derived from a Triatomine captured in Nicaragua. PCR based typification showed that this isolate, named Nicaragua, belonged to the lineage Tc I. Nicaragua infected culture cells were treated with allopurinol, showing different behavior according to the cellular compartment, being cardiomyocyte primary cultures more resistant to this drug. The course of the infection in a mice experimental model and its susceptibility to benznidazole and allopurinol was analyzed. In benznidazole treatment, mice reverted the high lethal effect of parasites during the acute infection, however, a few parasites were detected in the heart of 88% of mice 1 year post-infection. Since T. cruzi is a heterogeneous species population it is important to study and characterize different parasites actually circulating in humans in endemic areas. In this work we show that T. cruzi Nicaragua isolate, is sensitive to early benznidazole treatment.


Subject(s)
Chagas Disease/epidemiology , Chagas Disease/parasitology , Endemic Diseases , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/physiology , Allopurinol/pharmacology , Allopurinol/therapeutic use , Animals , Cell Line , Cells, Cultured , Chagas Disease/drug therapy , Inhibitory Concentration 50 , Insect Vectors/parasitology , Mice , Mice, Inbred C3H , Muscle Cells/parasitology , Muscles/parasitology , Muscles/pathology , Nicaragua/epidemiology , Nitroimidazoles/pharmacology , Nitroimidazoles/therapeutic use , Phylogeny , Rats , Triatoma/parasitology , Trypanocidal Agents/therapeutic use , Trypanosoma cruzi/classification
19.
Am J Trop Med Hyg ; 82(5): 861-4, 2010 May.
Article in English | MEDLINE | ID: mdl-20439967

ABSTRACT

We previously reported that the T cell compartment in chronically Trypanosoma cruzi-infected adult subjects display functional and phenotypic signs of immune senescence. This study aimed to investigate the differentiation and the senescent profile of the overall CD8(+) T cell compartment in T. cruzi-infected children at the early stage of the disease. We found a lower percentage of naive (CD27(+)CD28(+)CD45RA(+)) and early antigen-experienced (CD45RA(-)CD27(+)CD28(+)), and higher percentages of late differentiated antigen-experienced (CD45RA(-)CD27(-)CD28(-)) CD8(+) T cells in T. cruzi-infected children as compared with age-matched uninfected controls. The expression of the interleukin (IL)-7R is also decreased on naive and on antigen-experienced total CD8(+) T cells with various degrees of differentiation. Conversely, the expression of HLA-DR, caspase-3, and CD57 did not vary on the total CD8(+) T cell compartment. These findings suggest that the duration of the infection is relevant in the process of immune senescent that this parasite can induce.


Subject(s)
CD8-Positive T-Lymphocytes/physiology , Chagas Disease/immunology , Adolescent , Animals , Antigens, CD/genetics , Antigens, CD/metabolism , Case-Control Studies , Cell Differentiation , Child , Cytokines/genetics , Cytokines/metabolism , Gene Expression Regulation , Humans , Trypanosoma cruzi/immunology
20.
Microbes Infect ; 12(5): 359-63, 2010 May.
Article in English | MEDLINE | ID: mdl-20123034

ABSTRACT

Trypanosoma cruzi-specific immune responses were evaluated in a total of 88 subjects living in areas endemic of Chagas disease of Argentina by IFN-gamma ELISPOT assays and immunoblotting. Positive T. cruzi antigen-induced IFN-gamma responses were detected in 42% of subjects evaluated (15/26 positive by conventional serology and 22/62 seronegative subjects). Using immunoblotting, T. cruzi-specific IgG reactivity was detected in all seropositive subjects and in 11% (7/61) of subjects negative by conventional serology. Measurements of T cell responses and antibodies by immunoblotting, in conjunction with conventional serology, might enhance the capability of detection of exposure to T. cruzi in endemic areas.


Subject(s)
Chagas Disease/immunology , Trypanosoma cruzi/immunology , Adult , Aged , Antibodies, Protozoan/blood , Argentina , Endemic Diseases , Female , Humans , Immunoblotting , Immunoglobulin G/blood , Interferon-gamma/metabolism , Leukocytes, Mononuclear/immunology , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...